Related Experiment Video
Updated: Jun 14, 2025

Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
Published on: September 5, 2011
Pregnancy bleeding during second and third trimester: Is the Kleihauer-Betke test really useful?
Yoann Athiel1, Paul Maurice1, My-Anh Nghiem1
1Department of Fetal Medicine, Armand-Trousseau Hospital, AP-HP Sorbonne University, Paris, France; French Referral National Centre for Perinatal Hemobiology, Armand Trousseau Hospital, AP-HP Sorbonne Université, Paris, France.
The Kleihauer test showed limited usefulness for bleeding in late pregnancy. Most tests were negative, and no adverse outcomes were linked to bleeding or positive results.
Area of Science:
- Perinatal Hemobiology
- Maternal-Fetal Medicine
Background:
- Bleeding during the second and third trimesters of pregnancy requires careful evaluation.
- The Kleihauer test is used to detect fetal-maternal hemorrhage.
Purpose of the Study:
- To assess the clinical utility of the Kleihauer test in pregnant women experiencing bleeding in the second and third trimesters.
- To determine the rate of positive Kleihauer tests and their association with maternal and neonatal outcomes.
Main Methods:
- Retrospective single-center study of pregnant women with bleeding (15-42 weeks gestation).
- Analysis of clinical data, ultrasound findings, Kleihauer test results, and neonatal outcomes.
- Review of Kleihauer test data from a National Reference Center for Perinatal Hemobiology (CNRHP).
Main Results:
- The Kleihauer test was performed in 36.5% of cases, with no positive results.
- No significant abnormalities were found in fetal heart rate monitoring or Doppler ultrasound.
- 4.4% of newborns had mild anemia, none requiring intensive care or transfusion.
- At the CNRHP, only 0.5% of Kleihauer tests for bleeding were positive, with no associated adverse outcomes.
Conclusions:
- Systematic use of the Kleihauer test for bleeding in late pregnancy appears to have limited clinical value.
- Further research is needed to optimize guidelines for managing bleeding in pregnant women.
- Current evidence suggests the test may not significantly impact clinical management or neonatal outcomes in these cases.
More Related Videos
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
09:33Three-dimensional Rendering and Analysis of Immunolabeled, Clarified Human Placental Villous Vascular Networks
Published on: March 29, 2018